Nafcillin Sodium (nafcillin sodium)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Nafcillin is a semisynthetic penicillinase-resistant penicillin antibiotic.

Nafcillin shares the uses of other parenteral penicillinase-resistant penicillins (e.g., oxacillin) and generally is used only in the treatment of infections caused by, or suspected of being caused by, susceptible penicillinase-producing staphylococci. For specific information on the uses of nafcillin, see Uses in the Penicillinase-Resistant Penicillins General Statement 8:12.16.12.

Generic name: nafcillin sodium
Pronunciation: (naff-SIL-in)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Nafcillin Sodium

Intelligence content is not available yet.

Indications

The following indications are listed for Nafcillin Sodium:

  • Acute Staphylococcal Bacterial Sinusitis
  • Skin And Skin Structure Infection
  • Staphylococcal Meningitis
  • Staphylococcal Pneumonia
  • Staphylococcal Prosthetic Heart Valve Endocarditis
  • Staphylococcus Aureus Endocarditis
  • Staphylococcus Aureus Joint Infection
  • Staphylococcus Aureus Osteomyelitis
  • Staphylococcus Aureus Septicemia
  • Staphylococcus Aureus Skin And Skin Structure Infection
  • Staphylococcus Infections

Also known as: Acute Sinusitis Due To Staphylococcus Species, Acute Sinusitis Due To Staphylococcus Spp., Endocarditis Due To S. Aureus, Endocarditis Due To Staphylococcus Aureus, Infection Of Skin And/Or Subcutaneous Tissue, Joint Infection Due To Staphylococcus Aureus, Joint Infection Due To Staphylococcus Pyogenes Aureus, Meningitis Due To Staphylococcus Species, Meningitis Due To Staphylococcus Spp., Osteomyelitis Due To Staphylococcus Aureus, Osteomyelitis Due To Staphylococcus Pyogenes Aureus, Pneumonia Due To Staphylococcus Species, Pneumonia Due To Staphylococcus Spp., Prosthetic Heart Valve Endocarditis Due To Staphylococcus, Prosthetic Valvular Endocarditis Due To Staphylococcus, Prosthetic Valvular Staphylococcal Endocarditis, Pve Due To Staphylococcus, Pyogenic Bone Infection Due To Staphylococcus Aureus, Sepsis Due To Staphylococcus Aureus, Septicemia Due To Staph Aureus, Septicemia Due To Staphylococcus Aureus, Skin And Skin Soft Tissue Staphylococcus Aureus Infection, Skin And Soft Tissue Skin Infection, Staphylococcal Infectious Disease, Staphylococcus Species Infection, Staphylococcus Spp. Infection.

Dosing

Dosage of nafcillin sodium is expressed in terms of nafcillin. Dosage of the drug should be adjusted according to the type and severity of infection.

Modification of nafcillin dosage generally is unnecessary in patients with either renal impairment or hepatic impairment alone; however, modification of dosage may be necessary in patients with both severe renal impairment and hepatic impairment.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data